Précis
Not knowing the relationship between stem cells and cancer cells, we may unwittingly expose ourselves to some lurking danger.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247
Huff CA, Matsui W, Smith BD et al (2006) The paradox of response and survival in cancer therapeutics. Blood 107:431–434
Bach PB, Jett JR, Pastorino U et al (2007) Computed tomography screening and lung cancer outcomes. JAMA 297:953–961, Erratum in JAMA 2007;298(5):518
Arber DA, Tamayo R, Weiss LM (1998) Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol 29:498–504
Strohmeyer T, Reese D, Press M et al (1995) Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol 153:511–515
Natkunam Y, Rouse RV, Zhu S et al (2000) Immunoblot analysis of CD34 expression in histologically diverse neoplasms. Am J Pathol 156:21–27
Leaf C (2004) Why we’re losing the war on cancer (and how to win it) (Avastin, Erbitux, Gleevec...the new wonder drugs might make you think we’re finally beating this dreaded scourge. We’re not. Here’s how to turn the fight around.) Fortune Magazine, March 22, 2004, pp 77–92
Hong WK, Endicott J, Itri LM et al (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501–1505
Steinbach G, Lynch PM, Phillips RK et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952
Thompson IM, Goodman PJ, Tangen CM et al (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224
Tabar V, Tomishima M, Panagiotakos G et al (2008) Therapeutic cloning in individual parkinsonian mice. Nat Med 14:379–381
Pucéat M, Ballis A (2007) Embryonic stem cells: from bench to bedside. Clin Pharmacol Ther 82:337–339
Hacein-Bey-Abina S, von Kalle C, Schmidt M et al (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255–256
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tu, SM. (2010). Clinical Implications. In: Origin of Cancers. Cancer Treatment and Research, vol 154. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-5968-3_18
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5968-3_18
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-5967-6
Online ISBN: 978-1-4419-5968-3
eBook Packages: MedicineMedicine (R0)